IFT Provides Comments to FDA & FSIS

IFT provided written comments to FDA/FSIS focused on a number of topics, including sodium reduction technological innovations and challenges; monitoring sodium content for assessing sodium reduction initiatives; establishing and meeting voluntary sodium reduction targets; and others.

February 16, 2012

IFT provided written comments to FDA/FSIS focused on a number of topics, including sodium reduction technological innovations and challenges; monitoring sodium content for assessing sodium reduction initiatives; establishing and meeting voluntary sodium reduction targets; and others. In our comments, we emphasized the importance of investing in food science and technology research and development to stimulate meaningful, safe, and sustainable affects on sodium intake in the United States.

Read more

Story Tools